Malignancy-associated expression of ROR1 has been observed in B-cell chronic lymphocytic leukemia (B-CLL), mantle cell lymphoma (MCL), breast cancer, and ovarian cancer (178). This evidence concerns the gene ROR1 and mantle cell lymphoma.